Insurance giant Allstate (NYSE: ALL) reported Q2 CY2026 results beating Wall Street’s revenue expectations, with sales up 10.8% year on year to $18.6 billion. Its non-GAAP profit of $8.99 per share was 48% above analysts’ consensus estimates.

Is now the time to buy Allstate? Find out by accessing our full research report, it’s free.

"Consistent operating performance continues to generate attractive returns and deployable capital," said John Dugenske, President, Investments and Corporate Strategy.

Company Overview

Born from a Sears, Roebuck & Co. initiative during the Great Depression with its famous "You're in good hands" slogan, Allstate (NYSE: ALL) is one of America's largest personal property and casualty insurers, offering protection for autos, homes, and personal property.

Revenue Growth

Insurers earn revenue three ways. The core insurance business itself, often called underwriting and represented in the income statement as premiums earned, is one way. Investment income from investing the “float” (premiums collected upfront not yet paid out as claims) in assets such as fixed-income assets and equities is the second way. Fees from various sources such as policy administration, annuities, or other value-added services are the third. Over the last five years, Allstate grew its revenue at a decent 9% compounded annual growth rate. Its growth was slightly above the average insurance company and shows its offerings resonate with customers.

Long-term growth is the most important, but within financials, a half-decade historical view may miss recent interest rate changes and market returns. Allstate’s annualized revenue growth of 8.5% over the last two years aligns with its five-year trend, suggesting its demand was stable. Note: Quarters not shown were determined to be outliers because they were impacted by outsized investment gains/losses that are not indicative of the recurring fundamentals of the business.

This quarter, Allstate reported year-on-year revenue growth of 10.8%, and its $18.6 billion of revenue exceeded Wall Street’s estimates by 7.8%.

Net premiums earned made up 90.9% of the company’s total revenue during the last five years, meaning Allstate lives and dies by its underwriting activities because non-insurance operations barely move the needle.

While insurers generate revenue from multiple sources, investors view net premiums earned as the cornerstone — their direct link to core operations stands in sharp contrast to the unpredictability of investment returns and fees.

WHILE YOU’RE HERE: The Next Palantir? One satellite company captures images of every point on Earth. Every single day. The Pentagon wants it. Hedge funds are using it to beat earnings. You’ve probably never heard of it.

This is what the early days of Palantir looked like before it became a giant. Same playbook. Different technology. If you missed Palantir, you need to see this. Claim The Stock Ticker for Free HERE.

Book Value Per Share (BVPS)

Insurance companies are balance sheet businesses, collecting premiums upfront and paying out claims over time. The float — premiums collected but not yet paid out — is invested, creating an asset base supported by a liability structure. Book value captures this dynamic by measuring:

• Assets (investment portfolio, cash, reinsurance recoverables) - liabilities (claim reserves, debt, future policy benefits)

BVPS is essentially the residual value for shareholders.

We therefore consider BVPS very important to track for insurers and a metric that sheds light on business quality. While other (and more commonly known) per-share metrics like EPS can sometimes be lumpy due to reserve releases or one-time items and can be managed or skewed while still following accounting rules, BVPS reflects long-term capital growth and is harder to manipulate.

Allstate’s BVPS grew at a mediocre 7.1% annual clip over the last five years. However, BVPS growth has accelerated recently, growing by 40.1% annually over the last two years from $62.85 to $123.38 per share.

Over the next 12 months, Consensus estimates call for Allstate’s BVPS to grow by 10.1% to $123.47, decent growth rate.

Key Takeaways from Allstate’s Q2 Results

It was good to see Allstate beat analysts’ EPS expectations this quarter. We were also excited its net premiums earned outperformed Wall Street’s estimates by a wide margin. Zooming out, we think this was a solid print. The stock remained flat at $266.00 immediately after reporting.

Indeed, Allstate had a rock-solid quarterly earnings result, but is this stock a good investment here? We think that the latest quarter is only one piece of the longer-term business quality puzzle. Quality, when combined with valuation, can help determine if the stock is a buy. We cover that in our actionable full research report which you can read here (it’s free).